USP General Chapter 800 governs the handling of hazardous drugs in healthcare settings. It is frequently discussed alongside USP 797, and the two are routinely confused, but they exist for opposite reasons: 797 protects the preparation from the people; 800 protects the people from the preparation. That single inversion drives every engineering difference between them.
It applies to all personnel who handle hazardous drug preparations and to all entities that store, transport, compound or administer them – pharmacies, hospitals, clinics, veterinary practices and physician offices. Unlike 797, it is not limited to sterile preparations: a hazardous tablet that must be crushed falls under it.
What makes a drug hazardous, and who decides
USP 800 does not maintain its own list. It defers to the NIOSH List of Hazardous Drugs in Healthcare Settings, which is the entity that determines scope. A drug is listed on criteria including carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, and structural or toxicity similarity to a drug already listed.
The practical consequence for a facility is that scope is not fixed at design time. NIOSH revises the list, and a facility that was out of scope can come into it without changing anything it does. Designing containment that can be extended is cheaper than designing to the current list exactly.
The chapter does allow proportionality through an Assessment of Risk. For certain dosage forms – final dosage forms that require no manipulation, for instance – an entity may document an assessment and adopt alternative containment strategies rather than full containment. That assessment is a formal, written, reviewed document, not an informal judgement, and it must be revisited when the list or the practice changes.
The containment engineering controls
| Term | What it is | Requirement | Design consequence |
|---|---|---|---|
| C-PEC – containment primary engineering control | The cabinet or isolator the handling occurs in: Class II biological safety cabinet or a containment aseptic containment isolator | Externally vented | Ducted exhaust to outside is mandatory – this is not a recirculating cabinet and cannot be sited on convenience |
| C-SEC – containment secondary engineering control | The room housing the C-PEC | Negative pressure 0.01 to 0.03 in w.c., at least 12 ACH, externally vented | The negative pressure band is narrow at both ends – too little is non-compliant, too much causes door and airflow problems |
| Sterile HD compounding | C-PEC inside a classified C-SEC | C-SEC classified ISO 7 with an ISO 7 ante-room, and 30 ACH where USP 797 applies | This is where 797 and 800 must both be satisfied at once |
| C-SCA – containment segregated compounding area | An unclassified room containing a C-PEC | Negative pressure, at least 12 ACH, externally vented | Permitted, but restricts the preparation to the shortest beyond-use dating under USP 797 |
| HD storage | Where hazardous drugs are stored | Negative pressure, at least 12 ACH, externally vented | Storage is frequently forgotten in design and is a common inspection finding |
External venting is the requirement that most often forces a building decision. A recirculating cabinet does not satisfy 800 for the drugs that require containment, and ducting to atmosphere constrains where the room can sit, how the roof or facade is penetrated, how the exhaust is monitored, and what happens to the pressure cascade when the fan fails. Retrofitting a vent path into an occupied building is routinely the largest single line item in an 800 remediation.
The USP 797 and USP 800 conflict, and how it is actually resolved
This is the part worth reading twice, because it is where designs fail. For a sterile hazardous preparation both chapters apply simultaneously, and their pressure requirements are opposed:
| USP 797 wants | USP 800 wants | |
|---|---|---|
| Objective | Protect the preparation from contamination | Protect personnel from the drug |
| Room pressure | Positive relative to less clean spaces | Negative relative to adjacent spaces |
| Air handling | HEPA-filtered supply, 30 ACH in classified rooms | At least 12 ACH, externally vented, no recirculation |
| Air movement | Inward to the clean space | Inward to the contaminated space |
Neither yields to the other. The resolution is architectural rather than a compromise on either requirement: the sterility objective is met by the C-PEC, and the containment objective is met by the room. The ISO 5 environment the preparation needs exists inside the cabinet or isolator; the room around it runs negative and externally vented for the operator. The ante-room then provides the pressure step that lets a negative buffer room sit inside an otherwise positive suite.
Two failure modes follow from getting the cascade wrong. Run the containment room positive to satisfy 797 and hazardous aerosol migrates toward staff. Run the whole suite negative to satisfy 800 and unclassified corridor air is drawn across the sterile work. The pressure cascade has to be resolved across every door in the suite, including the failure cases – fan failure, door held open, filter loaded – before construction, because it cannot be tuned into compliance afterwards.
Cleaning is four steps here, not one
Ordinary cleanroom practice does not satisfy 800, because a hazardous residue is a chemical hazard rather than a microbial one. The chapter requires a sequence, and each step does something the others cannot:
| Step | What it does | Why it cannot be skipped |
|---|---|---|
| Deactivation | Renders the hazardous drug residue inert | A disinfectant does not deactivate a cytotoxic residue – it may simply spread it |
| Decontamination | Removes the deactivated residue from the surface | Deactivated residue is still residue and still transfers |
| Cleaning | Removes remaining soil | Conventional cleaning, and only meaningful after the two steps above |
| Disinfection | Kills microorganisms | Only relevant where sterile compounding also occurs – this is the 797 step |
The material consequence is durability. Deactivating agents are aggressive, and surfaces get four treatments where a non-hazardous cleanroom gets one. Surface and material selection has to be made against the deactivating agent, not against the disinfectant, or finishes degrade within the life of the facility and become uncleanable – which converts a materials decision into a compliance failure.
What this means if you are building or remediating
- Establish scope against the current NIOSH list, and design for it to grow. The list is revised; containment that can be extended costs less than containment sized exactly to today.
- Decide sterile or non-sterile early. Non-sterile hazardous handling needs containment alone; sterile hazardous compounding needs containment plus the full 797 classified suite, and the two scopes are not comparable in cost.
- Resolve the exhaust route before anything else. External venting constrains room location, roof or facade penetration, fan redundancy and monitoring. It is the hardest thing to change later.
- Draw the pressure cascade across every door, including failure cases, and include the storage room – storage is negative and 12 ACH too, and is the most commonly missed space.
- Select surfaces against the deactivating agent. Then confirm the selection survives the full four-step regime, not just a disinfectant wipe.
- Design in continuous pressure monitoring with a record. A gauge nobody reads is not monitoring, and the record is what an inspector asks for.
Like USP 797, chapter 800 is compendial rather than a federal regulation in itself, and it takes practical force through state boards of pharmacy, accreditation bodies and – because it concerns worker exposure – occupational safety enforcement. Confirm the position in your own state.
Related guides and tools
- USP 797 explained – the sterile compounding side, CSP categories and the classified suite.
- Cleanroom air change and HEPA calculator – airflow, filter count and ceiling fit.
- Cleanroom classifications and ISO 14644.
- Cleanroom design and construction.
Get a single-source quote
Standards referenced: USP 800 · USP 797 · ASME BPE · ISO 14644-1
Related: ISO 7 Cleanroom Requirements
A segregated containment area vs a classified containment area: which route a facility can use
USP 800 permits two physical arrangements, and the choice is made by dating and throughput rather than by preference. A containment segregated compounding area is an unclassified room holding an externally vented containment primary engineering control. It runs at negative pressure of 0.01 to 0.03 inch water column against adjacent spaces, at a minimum of 12 air changes per hour. Non-sterile hazardous drug work can be done there without further envelope. Sterile work can too, but only as a Category 1 preparation under USP 797. That caps beyond-use dating at 12 hours in controlled room temperature, or 24 hours refrigerated.
The classified route puts the same cabinet or isolator into a negative pressure ISO 7 buffer room with an ISO 7 anteroom in front of it, at a minimum of 30 air changes per hour. That is what supports Category 2 dating, where the useful life of a preparation is measured in days instead of hours.
The engineering gap between the two is not the cabinet, which is identical. It is the envelope and the air system. The classified route adds a second door with a pressure cascade across it, a classified ceiling and wall system, and particle classification in the operational state. It also adds an environmental monitoring program with a sampling plan, plus a gowning sequence performed in a fixed order. A pharmacy compounding a handful of patient-specific doses that are administered the same shift rarely needs any of that. A pharmacy that has to hold stock does, and no amount of procedure substitutes for the room.
Room count, not the square foot rate, is what moves a hazardous drug project budget
On our cleanroom cost guide, a full GMP facility build at ISO 7, Grade C, is recorded at $550 to $850 per square foot, and at ISO 8, Grade D, at $385 to $650. USP 800 usually leaves those rates alone. What it changes is how many rooms appear on the plan.
A compliant sterile hazardous drug operation carries a negative pressure receiving and storage area, the containment secondary engineering control itself, and an anteroom. Most plans add a separate non-hazardous buffer room, so ordinary sterile work is not forced into a negative pressure space. Every one of those is classified or controlled floor area billed at the rates above. The fittings follow the same pattern: gowning rooms, air showers and pass-throughs are listed there at $5,000 to $25,000 each, and a containment plan needs more of them, because a pressure cascade cannot be maintained through a door that two functions share.
Exhaust is the other one-way pressure on the number. Air leaving a containment area goes outdoors instead of returning to the air handler, so the supply side makes up that volume continuously. Mechanical scope is already 30 to 50 percent of a cleanroom project before that constraint is applied. Qualification runs 12 to 22 percent of project value on the same guide, and on a hazardous drug project it covers three separate report sets: containment verification of the cabinet or isolator, room pressure and air change testing, and surface wipe sampling.
What to require so a hazardous drug suite survives a board of pharmacy inspection
State boards of pharmacy inspect against USP 800, and they read documents. Require these before the suite is used:
- A written Assessment of Risk for every dosage form the entity intends to exclude from full containment. It should be signed and dated, name the NIOSH list revision it was written against, and state when it will be revisited.
- Certification of each containment primary engineering control to its own standard: NSF/ANSI 49 for a Class II biological safety cabinet, and for a containment isolator the manufacturer’s documented recovery time to ISO 5 conditions after a material transfer or an interruption.
- Proof the exhaust is external, as a measured airflow and duct pressure test plus mechanical drawings that show the discharge point and show no return path to any air handler.
- Pressure differential readings at every door in the containment path, recorded against the 0.01 to 0.03 inch water column range, with monitoring devices that log values rather than only display them.
- Air change rates calculated from measured supply and exhaust volumes rather than fan curves, at 12 per hour for a non-sterile containment area and 30 per hour for a sterile ISO 7 containment secondary engineering control.
- ISO 14644-1 particle classification of the buffer room and anteroom with the occupancy state printed on the certificate, since a room certified at rest has not been shown to hold classification while people work in it.
- A wipe sampling program written before the first sample: the surfaces, the marker compounds, the laboratory method, the action level, and the response when the action level is exceeded. The standard expects sampling at least every six months.
- Material compatibility statements for every product contact and room surface against the deactivating agent that will actually be used, because sodium hypochlorite is the common choice and it attacks stainless steel unless it is neutralized and rinsed.
- A cleaning procedure that names a specific product and contact time for each of deactivation, decontamination, cleaning and disinfection, rather than one product claimed to do all four.
Frequently asked questions
What is USP 800?
USP General Chapter 800 sets standards for handling hazardous drugs in healthcare settings, covering receipt, storage, compounding, transport, administration and disposal. Its purpose is to protect personnel, patients and the environment from exposure. It applies to all entities that handle hazardous drugs and to all personnel who do so, and it is not limited to sterile preparations.
What is the difference between USP 797 and USP 800?
They protect opposite things. USP 797 protects the preparation from contamination, which drives positive room pressure and HEPA-filtered air. USP 800 protects personnel from the drug, which drives negative pressure and mandatory external venting. Both apply at once to a sterile hazardous preparation, and neither overrides the other – the sterility objective is met by the containment cabinet and the containment objective by the room.
What pressure does USP 800 require?
Negative pressure between 0.01 and 0.03 inches water column relative to adjacent areas, in the containment secondary engineering control, in a containment segregated compounding area, and in hazardous drug storage. The band is narrow at both ends: too little is non-compliant and too much causes door operation and airflow problems.
How many air changes does USP 800 require?
At least 12 air changes per hour in containment areas and in hazardous drug storage. Where sterile hazardous compounding also brings USP 797 into scope, the classified room requirement of at least 30 air changes per hour applies as well – the higher figure governs, and the room must still be negative and externally vented.
Does USP 800 require external venting?
Yes. The containment primary engineering control must be externally vented, and containment rooms are externally vented with no recirculation. A recirculating cabinet does not satisfy the requirement. This is usually the hardest requirement to retrofit, because the exhaust route constrains room location, building penetration, fan redundancy and monitoring.
Which drugs does USP 800 apply to?
Those on the NIOSH List of Hazardous Drugs in Healthcare Settings. USP 800 does not maintain its own list – it defers to NIOSH, which lists drugs on criteria including carcinogenicity, teratogenicity, reproductive and organ toxicity at low doses, and genotoxicity. Because NIOSH revises the list, a facility can come into scope without changing anything it does.
What is an Assessment of Risk under USP 800?
A formal written assessment that lets an entity adopt alternative containment strategies for certain dosage forms rather than applying full containment – typically final dosage forms requiring no manipulation. It must be documented, reviewed and revisited when the NIOSH list or the practice changes. It is a governed document, not an informal judgement, and it is frequently examined at inspection.
What is the difference between a C-PEC and a C-SEC?
The containment primary engineering control is the cabinet or isolator the work happens in – a Class II biological safety cabinet or a containment aseptic containment isolator – and it must be externally vented. The containment secondary engineering control is the room housing it, which must be negative pressure, at least 12 air changes per hour and externally vented. The C-PEC contains the drug at the source; the C-SEC contains what escapes it.
Why does USP 800 cleaning have four steps?
Because a hazardous residue is a chemical hazard, not a microbial one. Deactivation renders the residue inert, decontamination removes it from the surface, cleaning removes remaining soil, and disinfection kills microorganisms where sterile compounding also applies. A disinfectant alone does not deactivate a cytotoxic residue and may simply spread it, which is why the order matters as much as the agents.
How does USP 800 affect surface and material selection?
Materially, and it is often overlooked. Surfaces receive four treatments rather than one, and deactivating agents are aggressive. Materials must be selected against the deactivating agent rather than against the disinfectant, or finishes degrade within the life of the facility and become uncleanable – turning a materials decision into a compliance failure that is expensive to remediate in an operating facility.
Is USP 800 enforceable?
It is a compendial chapter rather than a federal regulation in its own right, but it carries practical force through state boards of pharmacy that adopt it, through accreditation bodies, and – because it concerns worker exposure – through occupational safety enforcement. Adoption and timing vary by state, so confirm the position where you operate rather than assuming a single national effective date.
Can hazardous and non-hazardous compounding share a suite?
Yes, but the pressure cascade has to be designed for it rather than adapted afterwards. The non-hazardous buffer room runs positive under USP 797 while the containment room runs negative under USP 800, with the ante-room providing the pressure step between them. Adding containment to a suite designed only for positive pressure disturbs the cascade throughout and is usually more expensive than building both at the outset.
Where does the hazardous drug list come from?
From the National Institute for Occupational Safety and Health, which publishes and periodically updates a list of antineoplastic and other hazardous drugs in healthcare settings. The standard points to that list rather than defining the drugs itself.
What is a containment primary engineering control?
A ventilated device providing both an ISO class 5 environment for compounding and containment of the hazardous drug, such as a Class II biological safety cabinet or a containment isolator, externally vented where required.
What is a containment secondary engineering control?
The room housing the containment primary control, held negative to adjacent spaces with the required air changes and external exhaust. It is what stops contamination leaving the compounding area when the primary control is accessed.
What is a containment segregated compounding area?
A negative-pressure room containing a containment primary engineering control, used for a limited scope of preparations with restricted beyond-use dating. It is the reduced option where a full containment suite is not available.
Why is external venting required for hazardous drug compounding?
Because hazardous drug residue and vapour must not be recirculated into the building. Recirculating a containment cabinet through HEPA filtration removes particulate but does not remove vapour from volatile hazardous drugs.
What does receiving and unpacking require under the standard?
Hazardous drugs are received and unpacked in a neutral or negative-pressure area, not in a positive-pressure space where contamination could be pushed into clean areas. Damaged shipments are handled under a defined spill procedure.
What is an assessment of risk and what can it change?
A documented evaluation allowing alternative containment strategies for certain dosage forms of hazardous drugs that are not manipulated, based on the risk of exposure. It cannot be applied to antineoplastic drugs requiring manipulation, and it has to be reviewed periodically.
What deactivation, decontamination, cleaning and disinfection steps are required?
Deactivation renders the drug inert, decontamination removes residue from the surface, cleaning removes remaining soil, and disinfection addresses microbial contamination. Four distinct steps with different agents, and collapsing them into one wipe-down is the most common procedural failure.
What is wipe sampling and what does it show?
Surface sampling analysed for hazardous drug residue, used to demonstrate whether containment is working and where contamination is spreading. It is the only direct evidence that the containment strategy is effective in practice.
What personal protective equipment does the standard require?
Chemotherapy-rated gloves, protective gowns, and where indicated head, hair, shoe and face protection and respiratory protection, with defined change frequencies. The gloves and gowns have to be tested against the specific drug classes.
What spill control is required?
Spill kits accessible wherever hazardous drugs are handled, a written spill procedure, and personnel trained to use both. The procedure has to cover the size of spill beyond which the area is evacuated and specialist response is called.
How does hazardous drug handling change surface and material selection?
Surfaces have to withstand repeated application of aggressive deactivating and decontaminating agents, which rules out many finishes that would be acceptable in a standard cleanroom. Material selection is driven by the cleaning chemistry rather than by the classification.
What training does USP 800 require of personnel?
Initial and periodic training covering the hazardous drug list, the site assessment of risk, safe handling, personal protective equipment, spill response and the decontamination procedures, with competency documented before handling begins.
What is the difference between USP 800 vs 797?
USP 797 protects the patient: it sets the sterile compounding practices and the ISO-classified environment needed to keep a preparation sterile. USP 800 protects the worker and the environment: it covers the handling of hazardous drugs, sterile or not, from receipt through disposal. The USP 800 vs 797 distinction matters for facility design because 797 wants a positive-pressure buffer room while 800 requires hazardous sterile compounding in a negative-pressure room, so a pharmacy doing both needs two separately pressurized suites or an appropriately designed containment configuration.
What do the USP 800 guidelines require of the facility?
The USP 800 chapter requires hazardous drugs to be unpacked in a neutral or negative-pressure area, stored in an externally vented negative-pressure room with at least 12 air changes per hour, and compounded inside a containment primary engineering control (a Class II biosafety cabinet or compounding aseptic containment isolator) that sits in a containment secondary engineering control. For sterile compounding that room must be ISO 7, externally vented, at 30 air changes per hour and 0.01 to 0.03 in. w.g. negative to adjacent space. The USP 800 standards also cover PPE, closed-system transfer devices for administration, deactivation and decontamination procedures, spill control and medical surveillance. Those are the USP 800 guidelines a facility designer has to build to.
Is there a USP 800 compliance checklist, and where does the risk assessment come in?
A practical USP 800 compliance checklist works through: the hazardous drug list (the NIOSH list is the reference); the assessment of risk for each drug and dosage form; the receiving and unpacking area; storage room pressure, ventilation and venting; the C-PEC and C-SEC and their certification; PPE and its supply; closed-system transfer devices; deactivation, decontamination and cleaning SOPs; spill kits; training records; and medical surveillance. The USP 800 risk assessment is what lets a pharmacy handle certain dosage forms (for example, counting intact tablets) outside full containment; without a documented assessment, every drug on the list gets the full set of USP 800 requirements. USP 800 compliance is ultimately assessed by the state board of pharmacy and, for accredited facilities, by the accreditation survey.